IperionX Limited
NASDAQ:IPX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.98
58.73
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
IPX
stock under the Base Case scenario is
57.23
USD.
Compared to the current market price of 36.93 USD,
IperionX Limited
is
Undervalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for IperionX Limited.
| ZA |
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
|
| ZA |
A
|
Anglo American Platinum Ltd
JSE:AMS
|
|
| ZA |
S
|
Sibanye Stillwater Ltd
JSE:SSW
|
|
| ZA |
N
|
Northam Platinum Holdings Ltd
JSE:NPH
|
|
| ZA |
R
|
Royal Bafokeng Platinum Ltd
JSE:RBP
|
|
| MX |
|
Fresnillo PLC
LSE:FRES
|
|
| MX |
I
|
Industrias Penoles SAB de CV
BMV:PE&OLES
|
|
| CY |
T
|
Tharisa PLC
JSE:THA
|
|
| RU |
A
|
AK Alrosa PAO
MOEX:ALRS
|
|
| CN |
|
Sino-Platinum Metals Co Ltd
SSE:600459
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
IperionX Limited
Balance Sheet Decomposition
IperionX Limited
| Current Assets | 78.8m |
| Cash & Short-Term Investments | 77.1m |
| Receivables | 977.3k |
| Other Current Assets | 674.3k |
| Non-Current Assets | 37.1m |
| Long-Term Investments | 445k |
| PP&E | 22.5m |
| Intangibles | 14.1m |
| Other Non-Current Assets | -100 |
| Current Liabilities | 6.7m |
| Accounts Payable | 1.5m |
| Accrued Liabilities | 3.8m |
| Other Current Liabilities | 1.4m |
| Non-Current Liabilities | 3.6m |
| Long-Term Debt | 3.6m |
| Other Non-Current Liabilities | -100 |
Free Cash Flow Analysis
IperionX Limited
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
IperionX Limited
|
Revenue
|
4.8m
USD
|
|
Operating Expenses
|
-32m
USD
|
|
Operating Income
|
-27.3m
USD
|
|
Other Expenses
|
-294.6k
USD
|
|
Net Income
|
-27.6m
USD
|
IPX Profitability Score
Profitability Due Diligence
IperionX Limited's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
IperionX Limited's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
IPX Solvency Score
Solvency Due Diligence
IperionX Limited's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
IperionX Limited's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IPX Price Targets Summary
IperionX Limited
According to Wall Street analysts, the average 1-year price target for
IPX
is 36.47 USD
with a low forecast of 35.99 USD and a high forecast of 37.66 USD.
Dividends
Current shareholder yield for
IPX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IPX
stock under the Base Case scenario is
57.23
USD.
Compared to the current market price of 36.93 USD,
IperionX Limited
is
Undervalued by 35%.